Fighting to Breathe, a three-part series about lung disease in Kentucky, will air on KET starting Feb. 21.

LEXINGTON, Ky. (Feb. 21, 2022) — In 2009, Mark Evers, M.D., came to Kentucky to serve as the director of the University of Kentucky Markey Cancer Center with one overarching goal in mind: to reduce the significant burden of cancer in our state.

LEXINGTON, KY. (Feb. 17, 2022) — UK HealthCare announced a historic $10 million gift from Central Bank to support expanded patient care at the University of Kentucky Markey Cancer Center. The gift, announced at the UK Board of Trustees Health Care Committee meeting on Feb. 17, is the largest in UK HealthCare history and launches an initiative to raise $90 million to improve cancer care in Kentucky.

LEXINGTON, Ky. (Feb. 17, 2022) — A recent University of Kentucky Markey Cancer Center study gives more insight into how lung cancer differs in Kentucky compared to other U.S. populations.

LEXINGTON, Ky. (Feb. 17, 2022) — This year, the Martin Luther King (MLK) Center at the University of Kentucky celebrated 35 years on campus. To commemorate the occasion, the MLK Center hosted several events highlighting the historic milestone. Included in the event calendar was the inaugural Living Legacy Award ceremony.

LEXINGTON, Ky. (Feb. 16, 2022) — Anna-Maria South, MD, an assistant professor in the College of Medicine’s Division of Hospital Medicine and an attending physician on the Addiction Consult and Education Services at the University of Kentucky, has been selected as UK’s Bell Addiction Medicine Scholar for 2022. The mission of the Bell Alcohol and Addiction Endowed Chair is to build a broader base of physician education and training experiences in treating patients with substance use disorders at UK HealthCare.

Dr. Derek Allison is a co-investigator on an R01 entitled 'Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis'. The project will be utilizing MALDI-Mass Spectrometry Imaging and various other metabolomic studies in human samples and mouse models in collaboration with Dr. Ramon Sun, the project’s PI. It is a $2.5 million dollar grant and received a perfect 1% score from the NIH. Congratulations Dr. Allison!

Dr. Jing Di, PGY-1, has been selected to attend USCAP’s 2022 Annual Meeting with a Pathologist-in-Training Travel Award. This year’s annual meeting will be held March 19 – 24, 2022 at the Los Angeles Convention Center, Los Angeles, California.  Congratulations Dr. Di!

Our current Surgical Pathology Fellow, Dr. Justin Rueckert, is co-author of an article published in this month’s Archives of Pathology and Laboratory Medicine titled “Undiagnosed Malignancy and Therapeutic Complications in Oncology Patients: A 10-Year Review of Autopsy Cases”. For more detailed information, see the PubMed listing https://pubmed.ncbi.nlm.nih.gov/33836058/.  Congratulations Dr. Rueckert!